Stock Events

Stock Events

ANGLE S/ADR 

$0.067000
24
-$0.00-1.47% Tuesday 19:45

Statistics

Day High
0.068
Day Low
0.067
52W High
2.39
52W Low
0.0666
Volume
20,022
Avg. Volume
17,514
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

15JulExpected
Q4 2020
Q1 2021
Q1 2024
Q2 2024
Q1 2025
Q2 2025
Q2 2026
-0.04
-0.03
-0.01
0
Expected EPS
N/A
Actual EPS
N/A

Financials

-497.49%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
7.18MRevenue
-35.71MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides genomic sequencing solutions and competes with Angle in the liquid biopsy and cancer diagnostics market.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health specializes in liquid biopsies for cancer, directly competing with Angle's Parsortix system in capturing circulating tumor cells.
Fulgent Genetics
FLGT
Mkt Cap539.57M
Fulgent Genetics provides comprehensive genetic testing solutions, competing in the broader market of genetic analysis and diagnostics where Angle operates.
Pacific Biosciences of California
PACB
Mkt Cap435.16M
Pacific Biosciences offers sequencing systems that compete with Angle's technology in the genomics and diagnostics market.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen provides sample and assay technologies for molecular diagnostics, competing with Angle in the field of cancer diagnostics and genomic services.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Adaptive Biotechnologies
ADPT
Mkt Cap4.02B
Adaptive Biotechnologies focuses on the immune-driven medicine space, competing with Angle in leveraging biotechnologies for diagnostics and treatment insights.

About

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Show more...
CEO
Dr. Jan Groen Ph.D.
Employees
150
Country
United States

Listings

LSE
GB
CLBX.LSE
LSE
GB
AGL.LSE
OTC Link
US
ANPCF
F
DE
DWV.F

0 Comments

Share your thoughts

FAQ

What is ANGLE S/ADR stock price today?▼
The current price of ANPCY is $0.07 USD — it has decreased by -1.47% in the past 24 hours. Watch ANGLE S/ADR stock price performance more closely on the chart.
What is ANGLE S/ADR stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange ANGLE S/ADR stocks are traded under the ticker ANPCY.
Is ANGLE S/ADR stock price growing?▼
ANPCY stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year ANGLE S/ADR has showed a -92.45% decrease.
What is ANGLE S/ADR revenue for the last year?▼
ANGLE S/ADR revenue for the last year amounts to 7.18M USD.
What is ANGLE S/ADR net income for the last year?▼
ANPCY net income for the last year is -35.71M USD.
How many employees does ANGLE S/ADR have?▼
As of September 04, 2026, the company has 150 employees.
In which sector is ANGLE S/ADR located?▼
ANGLE S/ADR operates in the Health & Wellness sector.
When did ANGLE S/ADR complete a stock split?▼
ANGLE S/ADR has not had any recent stock splits.
Where is ANGLE S/ADR headquartered?▼
ANGLE S/ADR is headquartered in Guildford, United States.